Lemaitre Vascular (LMAT) Debt to Equity (2020 - 2021)
Lemaitre Vascular (LMAT) reported Debt to Equity of $0.14 for Q2 2021, down 66.28% year-over-year from $0.41 in Q2 2020, and up 774.08% on a QoQ basis from $0.02 in Q1 2021.
Lemaitre Vascular (LMAT) has 2 years of Debt to Equity data on file, last reported at $0.14 in Q2 2021.
- Quarterly Debt to Equity fell 66.28% year-over-year to $0.14 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $0.14 (down 66.28% YoY) and the FY2020 annual result came in at $0.22, changed N/A from the prior year.
- Debt to Equity climbed to $0.14 in Q2 2021 per LMAT's latest filing, from $0.02 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.41 in Q2 2020 and bottomed at $0.02 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 0.72 |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 0.04 |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 0.07 |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 1.02 |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 0.30 |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | - |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 1.57 |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 0.45 |
| 10 | Lemaitre Vascular | 2.28 Bn | 1.91 Bn | 48.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 0.14 |
| Mar 31, 2021 | 0.02 |
| Dec 31, 2020 | 0.22 |
| Sep 30, 2020 | 0.36 |
| Jun 30, 2020 | 0.41 |